Bringwell Pharma Private Limited
About Bringwell Pharma Private Limited
Data last updated:
Bringwell Pharma Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24230UP2020PTC137934. Its GSTIN is 09AAJCB4340A1Z3 (Uttar Pradesh).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Brij Raj Singh and Sunil Kumar Mangla.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at D01/001.1B DLF Dilsad Plaza Dilshad Extension Bhopura Sahibabad, Ghaziabad, Uttar Pradesh, India – 201005.
As per the financials filed for FY 2023, the company reported a revenue of ₹13.59 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.14 Lakh (net margin -8.4%) and EBITDA of -₹1.13 Lakh (EBITDA margin -8.3%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressD01/001.1B DLF Dilsad Plaza Dilshad Extension Bhopura Sahibabad, Ghaziabad, Uttar Pradesh, India – 201005
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Bringwell Pharma Private Limited
The main business activity of Bringwell Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Bringwell Pharma Private Limited FY 2023 filings available
Bringwell Pharma Private Limited reported revenue of ₹13.59 Lakh (up 344% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Bringwell Pharma Private Limited
Revenue rose 344% in the latest year. EBITDA rose 9% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Bringwell Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | -₹1.13 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.14 Lakh | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Bringwell Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -8.3% | •••• | •••• |
| Net Profit Margin | -8.4% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Bringwell Pharma are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Bringwell Pharma Private Limited
Bringwell Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mennis India Private Limited | ₹13.59 Lakh (FY 2023) | •••• | •••• | 74.0% | •••• | Delhi, India |
| Spanco Business Solutions Private Limited | ₹13.59 Lakh (FY 2023) | •••• | •••• | 26.0% | •••• | Bangalore, Karnataka, India |
| Aadi Info Solutions Private Limited | ₹13.59 Lakh (FY 2022) | •••• | •••• | 69.0% | •••• | Delhi, India |
| Swayansu Enterprises Private Limited | ₹13.59 Lakh (FY 2017) | •••• | •••• | •••• | Bhubaneswar, Odisha, India | |
| Dagadusheth Saraf & Sons Private Limited | ₹13.59 Lakh (FY 2018) | •••• | •••• | •••• | Phaltan, Maharashtra, India | |
| Bringwell Pharma Private Limited this company | ₹13.59 Lakh (FY 2023) | •••• | •••• | 344.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Iyi Brothers Private Limited | ₹13.59 Lakh (FY 2024) | •••• | •••• | 7.0% | •••• | Aurangabad, Maharashtra, India |
| Ryokona Pharmaceuticals Private Limited | ₹13.59 Lakh (FY 2025) | •••• | •••• | -34.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Bhalerao Farmer Producer Company Limited | ₹13.58 Lakh (FY 2025) | •••• | •••• | 149.0% | •••• | Parbhani, Maharashtra, India |
| SHN Fashion Private Limited | ₹13.58 Lakh (FY 2023) | •••• | •••• | -55.0% | •••• | Kolkata, West Bengal, India |
| Ideate FNB Private Limited | ₹13.58 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Jaipur, Rajasthan, India |
Peers are the five companies nearest above and the five nearest below Bringwell Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Bringwell Pharma Private Limited
Bringwell Pharma Private Limited is audited by ANKIT KRISHAN & COMPANY for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ANKIT KRISHAN & COMPANY | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Bringwell Pharma Private Limited
Bringwell Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Brij Raj Singh | Director | 12 Nov 2020 | 5 Years 11 Months | Current |
| Sunil Kumar Mangla | Director | 12 Nov 2020 | 5 Years 11 Months | Current |
Ownership and Shareholding of Bringwell Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Bringwell Pharma Private Limited
Bringwell Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Bringwell Pharma Private Limited
Bringwell Pharma Private Limited has a workforce of 0 employees as of Mar 30, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Bringwell Pharma Private Limited
Bringwell Pharma Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Brij Raj Singh was appointed as Director on 12 Nov 2020.
Credit Ratings, Litigation & Regulatory Alerts for Bringwell Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Bringwell Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Bringwell Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Bringwell Pharma Private Limited
Bringwell Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAJCB4340A1Z3 | Uttar Pradesh | Active | 01 Jan 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Bringwell Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bringwell Pharma Private Limited
Bringwell Pharma is an active private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 November 2020 (6+ years old) and is registered under CIN U24230UP2020PTC137934.
Bringwell Pharma reported revenue of ₹13.59 Lakh for FY 2023 (up 344% YoY).
Bringwell Pharma has 2 current directors:
- Brij Raj Singh - Director
- Sunil Kumar Mangla - Director
Bringwell Pharma reported a net loss of ₹1.14 Lakh (net margin -8.4%) and EBITDA of -₹1.13 Lakh (EBITDA margin -8.3%) for FY 2023, as per its filed financial statements.
The GSTIN of Bringwell Pharma is 09AAJCB4340A1Z3, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Bringwell Pharma is U24230UP2020PTC137934. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bringwell Pharma was incorporated on 12 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Bringwell Pharma by revenue are Mennis India Private Limited, Spanco Business Solutions Private Limited, Aadi Info Solutions Private Limited, Swayansu Enterprises Private Limited, Dagadusheth Saraf & Sons Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Brij Raj Singh was appointed as Director on 12 Nov 2020. Sunil Kumar Mangla was appointed as Director on 12 Nov 2020.
The registered office of Bringwell Pharma is at D01001.1B DLF Dilsad Plaza Dilshad Extension Bhopura Sahibabad, Ghaziabad, Uttar Pradesh, India – 201005.
Bringwell Pharma has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹5 Lakh.